INS and type 2 diabetes mellitus: Early intensive insulin treatment (CSII or MDI) proved superior to oral-only in meeting and maintaining the target of prolonged T2D remission upon discontinuation of 2–3-week-long initial treatment in the pivotal multicentric study by Weng J et al. [14].